Moderna Has a Promising Flu mRNA Vaccine. Trump's FDA Wants None of It
Moderna's flu shot dreams just hit a major snag. The FDA declined to approve its mRNA-based seasonal flu vaccine, reportedly after a senior official overruled the agency's scientific staff. This decision, shrouded in internal disagreement, raises serious questions about the future of mRNA technology